Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cue Health Inc (NQ: HLTH )

0.4112 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,274
Open 0.4112
Bid (Size) 0.4000 (27)
Ask (Size) 0.4221 (1)
Prev. Close 0.4112
Today's Range 0.4112 - 0.4112
52wk Range 0.3100 - 4.380
Shares Outstanding 78,250,469
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cue Health Adopts Limited-Duration Shareholder Rights Plan
From Cue Health Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Performance

YTD
-80.69%
-80.69%
1 Month
-18.45%
-18.45%
3 Month
+8.38%
+8.38%
6 Month
-78.01%
-78.01%
1 Year
-86.43%
-86.43%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Expert Ratings for Cue Health
Via Benzinga
Recap: Cue Health Q1 Earnings
Via Benzinga
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Cue Health to Present at Upcoming Investor Conferences
From Cue Health Inc.
Via Business Wire
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
Via News Direct
Exposures COVID-19 Product Safety
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
Via Benzinga
Exposures COVID-19 Product Safety
Cue Health Reports Second Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
From Cue Health Inc.
Via Business Wire
Cue Health to Announce Second Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
Cue Health’s Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
Via News Direct
Exposures COVID-19 Product Safety
Cue Health's Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
Via Benzinga
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
From Cue Health
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
Via Benzinga
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
From Cue Health Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Cue Health Reports First Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.